Sera Prognostics, Inc. Class A Common Stock (SERA) is a publicly traded Healthcare sector company. As of October 21, 2026, SERA trades at $2.03 with a market cap of $80.08M and a P/E ratio of -3.12. SERA moved +0.00% today. Year to date, SERA is -32.33%; over the trailing twelve months it is -39.58%. Its 52-week range spans $1.37 to $4.39. Analyst consensus is buy with an average price target of $0.00. Rallies surfaces SERA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for SERA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.03 |
| Market Cap | $80.08M |
| P/E Ratio | -3.12 |
| EPS | $-0.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.39 |
| 52-Week Low | $1.37 |
| Volume | 24.01K |
| Avg Volume | 0 |
| Revenue (TTM) | $70.00K |
| Net Income | $-33.23M |
| Gross Margin | -150.00% |
2 analysts cover SERA: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $0.00.